Endometrial safety, overall safety and tolerability of transdermal continuous combined hormone replacement therapy over 96 weeks: a randomized open-label study.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To establish whether transdermal continuous hormone replacement therapy (HRT) with
estrogen/progestogen provides adequate long-term endometrial protection in postmenopausal
women over a period of 96 weeks.